Rezolute Inc. (RZLT)
3.71
-0.15 (3.89%)
Upcoming Events
Latest Headlines
Form DEF 14A Rezolute, Inc. For: Dec 02
October 21, 2026 4:48 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
October 15, 2026 7:12 AM - StreetInsider
Rezolute (RZLT) Reiterated at Market Outperform by Citizens - 'upLIFT Results Locked in for Mid-December'
October 15, 2026 5:12 AM - StreetInsider
Form 8-K Rezolute, Inc. For: Oct 14
October 14, 2026 5:12 PM - SEC Filing
Rezolute completes enrollment in Phase 3 tumor hyperinsulinism study
October 14, 2026 4:05 PM - StreetInsider
Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
October 14, 2026 4:05 PM - StreetInsider
Form PRE 14A Rezolute, Inc. For: Dec 02
October 7, 2026 5:11 PM - SEC Filing
Rezolute (RZLT) PT Raised to $12 at Lake Street
October 6, 2026 8:52 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
October 6, 2026 6:57 AM - StreetInsider
Rezolute (RZLT) PT Raised to $15 at Citizens Post Positive FDA Feedback on cHI Ph3 Data
October 6, 2026 5:37 AM - StreetInsider
Cantor Fitzgerald Upgrades Rezolute (RZLT) to Overweight
October 5, 2026 4:43 PM - StreetInsider
Form 8-K Rezolute, Inc. For: Oct 05
October 5, 2026 8:00 AM - SEC Filing
FDA recommends pre-BLA meeting for Rezolute's congenital HI drug
October 5, 2026 7:00 AM - StreetInsider
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
October 5, 2026 7:00 AM - StreetInsider
Lake Street Starts Rezolute (RZLT) at Buy
September 30, 2026 7:40 AM - StreetInsider
Craig-Hallum Upgrades Rezolute (RZLT) to Buy
September 29, 2026 7:10 AM - StreetInsider
Rezolute (RZLT) PT Raised to $10 at H.C. Wainwright
September 28, 2026 6:55 AM - StreetInsider
Rezolute (RZLT) PT Raised to $10 at H.C. Wainwright
September 25, 2026 12:54 PM - StreetInsider
Rezolute (RZLT) Reiterated at Market Outperform by Citizens After Q4 Results
September 25, 2026 4:16 AM - StreetInsider
Form 10-K Rezolute, Inc. For: Jun 30
September 24, 2026 4:25 PM - SEC Filing
Form 8-K Rezolute, Inc. For: Sep 24
September 24, 2026 4:17 PM - SEC Filing
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
September 24, 2026 4:05 PM - StreetInsider
FDA continues review of Rezolute's congenital HI drug data
September 9, 2026 7:00 AM - StreetInsider
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
September 9, 2026 7:00 AM - StreetInsider
Rezolute to Participate in Upcoming Investor Conferences
September 2, 2026 7:30 AM - StreetInsider
Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
August 14, 2026 6:14 AM - SEC Filing
Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BANK OF AMERICA CORP /DE/
August 12, 2026 12:27 PM - SEC Filing
Form SCHEDULE 13G Rezolute, Inc. Filed by: Dellora Investments LP
August 12, 2026 11:05 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
July 30, 2026 6:53 AM - StreetInsider
Full Article List
